Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils

Scandinavian Journal of Immunology

Volumn 45, Issue 3, 1997, Pages 269-275

  Capsoni, F ^a,b   Minonzio, F ^a   Ongari, A M ^a   Carbonelli, V ^a   Galli, A ^a   Zanussi, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; FC RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CHEMOLUMINESCENCE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031043714     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-393.x     Document Type: Article

References (36)

1. Fiorentino DF, Bond MW, Mosmann TR, Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
2. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-60.
3. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
4. Moore KW, O'Garra A, de Wall Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-71.
5. Hsu DH, Moore KW, Spits H. Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphokine-activated killer activity. Intern Immunol 1992;4:563-9.
6. de Waal Malefiyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.
7. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
8. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 1992;148:1792-6.
9. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992;175:169-74.
10. Te Velte AA, de Waal Malefijt R, Huijbens RJF, De Vries JE, Figdor CG. IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-γ, IL-4, and IL-10. J Immunol 1992;149:4048-52.
11. de Waal Malefyt R, Figdor CG, Huijbens R et al. Effect of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes. J Immunol 1993;151:6370-81.
12. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C. IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-γ. J Leukoc Biol 1995;58:351-8.
13. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
14. Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 1994;83:2678-83.
15. Petroni KC, Shen L, Guyre PM. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated dunctions by IFN-γ and glucocorticoids. J Immunol 1988;140:3467-72.
16. Capsoni F, Minonzio F, Ongari AM et al. Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV-infected subjects. Clin Exp Immunol 1992;90:175-80.
17. Berton G, Zeni L, Cassatella MA, Rossi F. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 1986;138:1276-82.
18. Cassatella MA, Cappelli R, Della Bianca V, Grzeskowiak M, Dusi S, Berton G. Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis. Immunology 1988;63:499-506.
19. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. J Immunol 1985;135:2069-73.
20. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. J Lab Clin Invest 1968;21:77-89.
21. Poncelet O, Carayon P. Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J Immunol Methods 1985;85:65-74.
22. Roos D, Bot AAM, Van Schaik MLJ, De Boer M, Daha MR. Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations. J Immunol 1981;126:433-7.
23. Metcalf JA, Gallin JI, Nauseef WM, Root RK eds. Laboratory Manual of Neutrophil Function. New York: Raven Press, 1986.
24. Minkenberg I, Ferber E. Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes. J Immunol Methods 1984;71:61-7.
25. Aniansson H, Stendahl O, Dahlgren C. Comparison between luminol-and lucigenin-dependent chemiluminescence of polymorphonuclear leukocytes. Acta Path Microbiol Immunol Scand 1984;92: 357-61.
26. Tripathi AK, Taplits M, Puri J, Hoffman T. Down-regulation of surface FcRI and decrease in antibody-dependent cellular cytotoxicity of cultured monocytes. Reversal by monesin or cytochalasin-D. J Immunol 1991;146:1309-15.
27. Gallin JI. Disorders of phagocytic cells. In: Gallin JI, Goldstein IM, Snyderman R eds. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1992:859-74.
28. Katz P, Fauci AS. Antibody-dependent cytotoxicity in Chronic Granulomatous Disease. In: Gallin JI, Fauci AS eds. Advances in Host Defense Mechanisms, Vol. 3. New York: Raven Press, 1983:227-47.
29. Kuga S, Otsuka T, Niiro H. Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp Hematol 1996;24:151-7.
30. Rüegg SJ, Jungi TW. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells. Immunology 1988;63:513-20.
31. Van Schie RCAA, Verstraten RGG, Van de Winkel JGJ, Tax WJM, De Mulder PHM. Effect of recombinant IFN-γ (rIFN-γ) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-γ decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism. J Immunol 1992;148:169-76.
32. Roberts RL, Ank BJ, Fanger MW, Shen L, Stiehm ER. Role of oxygen intermediates in cytotoxicity: studies in Chronic Granulomatous Disease. Inflammation 1993;17:77-92.
33. Amezaga MA, Bazzoni F, Sorio C, Rossi F, Cassatella MA. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon γ-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (FcγR-I) in human polymorphonuclear leukocytes. Blood 1992;79:735-44.
34. Cassatella MA, Bazzoni F, Flynn RM, Dusi F, Trinchieri G, Rossi F. Molecular basis of interferon-γ and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J Biol Chem 1990;265:20241-6.
35. Klebanoff SJ, Olszowski S, Van Voorhis WC, Ledbetter JA, Waltersdorph AM, Schlechte KG. Effects of γ-interferon on human neutrophils: protection from deterioration on storage. Blood 1992;80:225-34.
36. Rotrosen D. The respiratory burst oxidase, In: Gallin JI, Goldstein IM, Snyderman R eds. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press, 1992:589-601.